EDEN — Eden Research Income Statement
0.000.00%
Last trade - 00:00
- £24.53m
- £24.36m
- £1.83m
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.77 | 1.83 | 1.37 | 1.23 | 1.83 |
Cost of Revenue | |||||
Gross Profit | 1.54 | 0.884 | 0.632 | 0.561 | 0.83 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.27 | 3.18 | 3.9 | 4.44 | 4.39 |
Operating Profit | -0.497 | -1.36 | -2.54 | -3.21 | -2.57 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -0.533 | -1.48 | -2.55 | -3.4 | -2.57 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.335 | -1.13 | -2.26 | -2.78 | -2.24 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.335 | -1.14 | -2.27 | -2.79 | -2.24 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.335 | -1.14 | -2.27 | -2.79 | -2.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.002 | -0.005 | -0.006 | -0.007 | -0.006 |
Dividends per Share |